PortfoliosLab logoPortfoliosLab logo
NASA vs. CANC
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

NASA vs. CANC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Tema Space Innovators ETF (NASA) and Tema Oncology ETF (CANC). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period


NASA

1D
-9.48%
1M
1.71%
YTD
6M
1Y
3Y*
5Y*
10Y*

CANC

1D
-2.20%
1M
-2.57%
YTD
4.92%
6M
3.88%
1Y
42.50%
3Y*
114.10%
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

NASA vs. CANC - Yearly Performance Comparison


2026 (YTD)
NASA
Tema Space Innovators ETF
29.65%
CANC
Tema Oncology ETF
-0.72%

Correlation

The correlation between NASA and CANC is 0.37, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (All Time)
Calculated using the full available price history since Apr 1, 2026

0.37

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

NASA vs. CANC — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NASA

CANC
CANC Risk / Return Rank: 7171
Overall Rank
CANC Sharpe Ratio Rank: 6464
Sharpe Ratio Rank
CANC Sortino Ratio Rank: 6767
Sortino Ratio Rank
CANC Omega Ratio Rank: 5757
Omega Ratio Rank
CANC Calmar Ratio Rank: 9090
Calmar Ratio Rank
CANC Martin Ratio Rank: 7777
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NASA vs. CANC - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Tema Space Innovators ETF (NASA) and Tema Oncology ETF (CANC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

NASA vs. CANC - Sharpe Ratio Comparison


Loading charts...

Sharpe Ratios by Period


NASACANCDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

2.02

Sharpe Ratio (All Time)

Calculated using the full available price history

5.20

-0.04

+5.23

Drawdowns

NASA vs. CANC - Drawdown Comparison

The maximum NASA drawdown since its inception was -22.08%, smaller than the maximum CANC drawdown of -97.53%. Use the drawdown chart below to compare losses from any high point for NASA and CANC.


Loading charts...

Drawdown Indicators


NASACANCDifference

Max Drawdown

Largest peak-to-trough decline

-22.08%

-97.53%

+75.45%

Max Drawdown (1Y)

Largest decline over 1 year

-8.67%

Max Drawdown (3Y)

Largest decline over 3 years

-30.27%

Current Drawdown

Current decline from peak

-22.08%

-56.51%

+34.43%

Average Drawdown

Average peak-to-trough decline

-3.70%

-73.16%

+69.46%

Ulcer Index

Depth and duration of drawdowns from previous peaks

3.32%

Volatility

NASA vs. CANC - Volatility Comparison


Loading charts...

Volatility by Period


NASACANCDifference

Volatility (1M)

Calculated over the trailing 1-month period

6.90%

Volatility (6M)

Calculated over the trailing 6-month period

16.73%

Volatility (1Y)

Calculated over the trailing 1-year period

61.27%

23.25%

+38.02%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

61.27%

280.04%

-218.77%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

61.27%

280.04%

-218.77%

NASA vs. CANC - Expense Ratio Comparison

Both NASA and CANC have an expense ratio of 0.75%.


Dividends

NASA vs. CANC - Dividend Comparison

NASA has not paid dividends to shareholders, while CANC's dividend yield for the trailing twelve months is around 0.05%.


PositionTTM202520242023
CANC
Tema Oncology ETF
0.05%0.06%3.00%0.56%
NASA
Tema Space Innovators ETF
0.00%0.00%0.00%0.00%

Frequently Asked Questions


NASA and CANC have a correlation of 0.37, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Both ETFs have the same 0.75% expense ratio. The better choice depends on whether you care most about return, fees, risk, or income.

NASA and CANC have the same expense ratio: 0.75% per year.

CANC has the higher dividend yield at 0.05%, compared with 0.00% for NASA.

NASA is categorized as Aerospace & Defense, while CANC is Health & Biotech Equities.

Portfolio Optimizer

Find the right allocation for NASA and CANC

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer